Cullinan Oncology
CGEM
CGEM
146 hedge funds and large institutions have $799M invested in Cullinan Oncology in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 54 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.51% more ownership
Funds ownership: 112.11% → 112.62% (+0.51%)
27% less capital invested
Capital invested by funds: $1.09B → $799M (-$288M)
62% less call options, than puts
Call options by funds: $559K | Put options by funds: $1.45M
Holders
146
Holding in Top 10
9
Calls
$559K
Puts
$1.45M
Top Buyers
| 1 | +$15.3M | |
| 2 | +$10.6M | |
| 3 | +$10.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$8.86M |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
+$4.38M |
Top Sellers
| 1 | -$38.9M | |
| 2 | -$25.7M | |
| 3 | -$7.11M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$4.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.96M |